[(3S,5S)-5-(Hydroxymethyl)-3-pyrrolidinyl]carbamic acid tert-butyl ester, 95.0%, 5g

(3aS,8aR)-2-(Pyrazin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 100mg

Methyl 2-amino-5-fluorobenzoate, 98.0%, 10g

Ethyl 2,4-dichlorobenzoylformate, 97.0%, 25g

Methyl 2-aminoisobutyrate hydrochloride, 95.0%, 500g

2-Isopropoxy-4,4,6-trimethyl-1,3,2-dioxaborinane>97.0%(T)5g

Ethyl chromane-2-carboxylate, 97%, 1g

Karl Fischer Roti®hydroquant C2, 2 mg H2O/ml, sin piridina, 1 l, envase de vidrio

3,5-Bis(trifluoromethyl)phenol>96.0%(GC)25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid, 97%, 250mg

(2-Amino-5-bromopyridin-3-yl)methanol, 97.0%, 5g

Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate, 97%, 250mg

Triethoxy-1H,1H,2H,2H-tridecafluoro-n-octylsilane>97.0%(GC)5g